Charles McWherter

No open positions remaining

71 year

Health Technology

Consumer Services

Profile

Charles A. McWherter worked as Vice President-Drug Discovery at Sugen, Inc. from 2001 to 2003.
From 2003 to 2007, served as VP & Head-Cardiovascular Therapeutics Areas at Pfizer Inc. Between 2007 and 2024, held the position of President-Research & Development at CymaBay Therapeutics, Inc. from 2022 to 2024.
In 2024 to 2025, was Independent Director at 89bio, Inc. Education includes a doctorate from Cornell University.

Former positions of Charles McWherter

Companies	Position	End
89BIO, INC.	Director/Board Member	2025-10-29
CYMABAY THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2024-03-21
PFIZER INC.	Corporate Officer/Principal	2006-12-31
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products	Corporate Officer/Principal	2002-12-31

See the detail of Charles McWherter's experience

Training of Charles McWherter

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles McWherter's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Sugen, Inc. Sugen, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs and related pharmaceutical products	Health Technology
CymaBay Therapeutics, Inc. CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases	Health Technology
Cornell University Cornell University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
89bio, Inc. 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company	Health Technology